Averie Giles
Family · Winchester, VANPI 1649644642
Payments from drug & device makers
Across 279 payments — averaging $32.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Abbott$942
- Collegium Pharmaceutical, Inc.$829
- Boston Scientific$610
- Nevro Corp.$463
- Globus Medical$367
- plus $3K from 26 others
What the payments were for
- Travel & lodging$1,02011%
- Food & beverage$8,00087%
- Education$1622%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 55 | $3,046 |
| Abbott | 39 | $942 |
| Collegium Pharmaceutical, Inc. | 49 | $829 |
| Boston Scientific | 18 | $610 |
| Nevro Corp. | 11 | $463 |
| Globus Medical | 12 | $367 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 15 | $303 |
| Biotronik NRO, Inc. | 4 | $298 |
| GRT US Holding, Inc. | 8 | $247 |
| Tersera Therapeutics LLC | 10 | $226 |
| Nalu Medical, Inc. | 10 | $212 |
| Relievant Medsystems, Inc. | 4 | $212 |
| MML US, Inc. | 9 | $200 |
| IBSA Pharma Inc. | 7 | $145 |
| Stryker | 1 | $129 |
| Vertex | 2 | $129 |
| Averitas Pharma Inc. | 5 | $128 |
| AbbVie | 1 | $127 |
| Vertos Medical, Inc. | 1 | $115 |
| Idorsia Pharmaceuticals US Inc | 1 | $94 |
| Spinal Simplicity, LLC | 3 | $87 |
| Pacira Pharmaceuticals Incorporated | 1 | $36 |
| Pfizer | 2 | $36 |
| Metacel Pharmaceuticals LLC | 2 | $28 |
| Hikma Pharmaceuticals USA | 2 | $26 |
| Bioventus LLC | 1 | $26 |
| Ultragenyx Pharmaceutical Inc. | 1 | $22 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $22 |
| Fidia Pharma USA Inc. | 1 | $21 |
| Kyowa Kirin, Inc. | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $19 |
| SPR Therapeutics, Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$1,318
- Intracept$602
- Prospera$253
- mild Device Kit$245
- INTELLIS ADAPTIVESTIM$153
- QULIPTA$127
- UBRELVY$127
- Senza$123
- PROCLAIM$105
How this compares
$9,182 in reported general payments places this provider in the 95th percentile of 4,332 family providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 118 | $57,508 |
| BelbucaBuprenorphine Hcl | 45 | $34,473 |
| OxycontinOxycodone Hcl | 40 | $25,129 |
| Buprenorphine | 80 | $20,204 |
| Fentanyl | 190 | $15,487 |
| MovantikNaloxegol Oxalate | 36 | $14,403 |
| Morphine Sulfate ErMorphine Sulfate | 420 | $10,781 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 552 | $10,539 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 598 | $9,424 |
| Gabapentin | 430 | $8,039 |
| Tramadol Hcl ErTramadol Hcl | 143 | $7,506 |
| Pregabalin | 296 | $6,202 |
| SymproicNaldemedine Tosylate | 11 | $5,807 |
| Hysingla ErHydrocodone Bitartrate | 14 | $5,600 |
| Tramadol Hcl | 404 | $3,465 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca | $829 | $91,980163 claims |
| Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate | $26 | $20,42094 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,332 family providers in Virginia.
Other family in Winchester
- Stacy KonyarWinchester$45K
- Colleen NappiWinchester$30K
- Robert FoxWinchester$18K
- Kimberley ChitkoWinchester$14K
- Andrea CottonVirginia Beach$696K
- Susan MooreWytheville$438K
- Ellen WermterCharlottesville$251K
- Dana StallingsFranklin$225K
- Jocelyn BrackettHerndon$199K
- Hochong Smith GillesRichmond$131K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.